ReviewFrontiers in oncology2014
Oncolytic virotherapy as emerging immunotherapeutic modality: potential of parvovirus h-1.
Markus Moehler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ReviewFrontiers in oncology2014
Markus Moehler et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.